These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10516837)

  • 1. [Comment of J. Fritze: Is therapy of obesity with orlistat medically necessary?].
    Wirth A
    Versicherungsmedizin; 1999 Sep; 51(3):137-8; author reply 138-9. PubMed ID: 10516837
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the long-term efficacy and tolerability of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity in primary care?
    Leiser JP; Gunning K
    J Fam Pract; 2000 Jun; 49(6):572-3. PubMed ID: 10923560
    [No Abstract]   [Full Text] [Related]  

  • 3. Outdated and misleading review of orlistat.
    Van R; Walt L
    Can Fam Physician; 1999 Dec; 45():2849-50, 2852. PubMed ID: 10626048
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.
    Lacey LA; Wolf A; O'shea D; Erny S; Ruof J
    Int J Obes (Lond); 2005 Aug; 29(8):975-82. PubMed ID: 15852050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does orlistat really offer help for the treatment of obesity?].
    Orozco P
    Aten Primaria; 1999 Nov; 24(8):445-6. PubMed ID: 10630025
    [No Abstract]   [Full Text] [Related]  

  • 6. Orlistat for the treatment of obesity: cost utility model.
    Foxcroft DR
    Obes Rev; 2005 Nov; 6(4):323-8. PubMed ID: 16246217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More about orlistat.
    Lucas KH; Kaplan-Machlis B
    Pharmacotherapy; 2000 Jul; 20(7):872-3. PubMed ID: 10907983
    [No Abstract]   [Full Text] [Related]  

  • 8. National trends in the use and costs of anti-obesity medications in England 1998-2005.
    Srishanmuganathan J; Patel H; Car J; Majeed A
    J Public Health (Oxf); 2007 Jun; 29(2):199-202. PubMed ID: 17494061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological sheet. Orlistat, oral administration (Xenical, Alli). ].
    J Pharm Belg; 2009 Jun; (2):67-8. PubMed ID: 19739531
    [No Abstract]   [Full Text] [Related]  

  • 10. A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.
    Lamotte M; Annemans L; Lefever A; Nechelput M; Masure J
    Diabetes Care; 2002 Feb; 25(2):303-8. PubMed ID: 11815500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orlistat.
    Nurs Times; 2006 May 2-8; 102(18):27. PubMed ID: 16703990
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study.
    Czernichow S; Knol MJ; Fezeu L; Grobbee DE
    Eur J Prev Cardiol; 2012 Jun; 19(3):484-9. PubMed ID: 21464100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orlistat and obesity: be aware of lichenoid drug eruption.
    Koca Kalkan I; Kalpaklioglu AF; Atasoy P; Karabulut AA
    Eur J Dermatol; 2011; 21(3):456-7. PubMed ID: 21680292
    [No Abstract]   [Full Text] [Related]  

  • 14. Spotlight on orlistat in the management of patients with obesity.
    Curran MP; Scott LJ
    Treat Endocrinol; 2005; 4(2):127-9. PubMed ID: 15783249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. About orlistat.
    Chabrol H; Péresson G; Callahan S
    Eat Weight Disord; 2001 Sep; 6(3):171-3. PubMed ID: 11589420
    [No Abstract]   [Full Text] [Related]  

  • 16. Diet-drug dilemma.
    Blackburn G
    Health News; 1999 Jun; 5(7):2. PubMed ID: 10932774
    [No Abstract]   [Full Text] [Related]  

  • 17. Orlistat: a review of its use in the management of patients with obesity.
    Curran MP; Scott LJ
    Drugs; 2004; 64(24):2845-64. PubMed ID: 15563254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is orlistat medically essential for the treatment of obesity?].
    Fritze J
    Versicherungsmedizin; 1999 Mar; 51(1):36-7. PubMed ID: 10200615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of orlistat in weight management.
    Marks S
    Aust Fam Physician; 2001 Apr; 30(4):335-8. PubMed ID: 11355219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orlistat: Current issues for patients with type 2 diabetes.
    Mancino JM
    Curr Diab Rep; 2006 Nov; 6(5):389-94. PubMed ID: 17077001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.